Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IDH2R172 mutation in angioimmunoblastic T-cell lymphoma: A retrospective multicenter case series.
Riva M, Tisi MC, Bertorelle R, Famengo B, D'Amore ESG, Pizzi M, Parisi A, Boscato E, Mazzucco M, Semenzato G, Krampera M, Gherlinzoni F, Trentin L, Ruggeri M, Visco C, Stefani PM, Piazza F. Riva M, et al. Among authors: bertorelle r. Eur J Haematol. 2023 Feb;110(2):217-220. doi: 10.1111/ejh.13885. Epub 2022 Oct 31. Eur J Haematol. 2023. PMID: 36264618 No abstract available.
Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
Terrin L, Trentin L, Degan M, Corradini I, Bertorelle R, Carli P, Maschio N, Bo MD, Noventa F, Gattei V, Semenzato G, De Rossi A. Terrin L, et al. Among authors: bertorelle r. Leukemia. 2007 May;21(5):965-72. doi: 10.1038/sj.leu.2404607. Epub 2007 Mar 8. Leukemia. 2007. PMID: 17344921
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases.
Visentin A, Imbergamo S, Frezzato F, Pizzi M, Bertorelle R, Scomazzon E, Berno T, Riva M, Piva E, Facco M, Piazza F, Semenzato G, Trentin L. Visentin A, et al. Among authors: bertorelle r. Oncotarget. 2017 Sep 28;8(66):110727-110731. doi: 10.18632/oncotarget.21304. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299182 Free PMC article.
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients.
Bonifacio M, Montemezzi R, Parisi A, De Matteis G, Bertorelle R, Scaffidi L, Candiotto C, Lippi G, Zamò A, Chilosi M, Pizzolo G, Scarpa A, Krampera M. Bonifacio M, et al. Among authors: bertorelle r. Ann Hematol. 2019 Oct;98(10):2339-2346. doi: 10.1007/s00277-019-03741-8. Epub 2019 Jun 27. Ann Hematol. 2019. PMID: 31250082 Clinical Trial.
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience.
Calabretto G, Attardi E, Teramo A, Trimarco V, Carraro S, Mossuto S, Barilà G, Vicenzetto C, Gasparini VR, Crugnola M, Niscola P, Poloni A, Giai V, Gaidano V, Finelli C, Bertorelle R, Candiotto C, Pizzi M, Binotto G, Facco M, Vianello F, Trentin L, Semenzato G, Zambello R, Santini V. Calabretto G, et al. Among authors: bertorelle r. Leukemia. 2022 Jul;36(7):1947-1950. doi: 10.1038/s41375-022-01592-3. Epub 2022 May 21. Leukemia. 2022. PMID: 35597805 Free PMC article. No abstract available.
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC".
Di Giusto S, Toffoletti E, Bonifacio M, Binotto G, Miggiano MC, Calistri E, Stulle M, Ermacora A, Stella R, Scaffidi L, D'Amore F, Scotton G, Griguolo D, De Matteis G, Bertorelle R, Krampera M, Semenzato G, Fanin R, Damiani D, Tiribelli M. Di Giusto S, et al. Among authors: bertorelle r. Cancer Med. 2023 Feb;12(3):3180-3184. doi: 10.1002/cam4.5158. Epub 2022 Oct 8. Cancer Med. 2023. PMID: 36208021 Free PMC article.
91 results